Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 20.64
(5.84%)
CNY 20.64
(5.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.03 Billion CNY | -4.04% |
| 2022 | 3.15 Billion CNY | 11.65% |
| 2021 | 2.82 Billion CNY | 19.54% |
| 2020 | 2.36 Billion CNY | 100.56% |
| 2019 | 1.18 Billion CNY | 38.12% |
| 2018 | 854.32 Million CNY | 14.95% |
| 2017 | 743.2 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3 Billion CNY | -3.18% |
| 2024 Q1 | 3.06 Billion CNY | 1.08% |
| 2024 Q2 | 3.09 Billion CNY | 1.14% |
| 2023 FY | 3.03 Billion CNY | -4.04% |
| 2023 Q2 | 3.23 Billion CNY | 3.62% |
| 2023 Q1 | 3.11 Billion CNY | -1.3% |
| 2023 Q4 | 3.03 Billion CNY | -4.59% |
| 2023 Q3 | 3.17 Billion CNY | -1.66% |
| 2022 Q2 | 3.06 Billion CNY | 4.06% |
| 2022 FY | 3.15 Billion CNY | 11.65% |
| 2022 Q4 | 3.15 Billion CNY | 1.99% |
| 2022 Q3 | 3.09 Billion CNY | 1.19% |
| 2022 Q1 | 2.94 Billion CNY | 3.97% |
| 2021 FY | 2.82 Billion CNY | 19.54% |
| 2021 Q2 | 2.43 Billion CNY | 4.39% |
| 2021 Q3 | 2.6 Billion CNY | 7.08% |
| 2021 Q4 | 2.82 Billion CNY | 8.57% |
| 2021 Q1 | 2.33 Billion CNY | -1.5% |
| 2020 Q3 | 1.31 Billion CNY | 4.28% |
| 2020 FY | 2.36 Billion CNY | 100.56% |
| 2020 Q2 | 1.26 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 2.36 Billion CNY | 80.06% |
| 2019 Q4 | 1.18 Billion CNY | 0.0% |
| 2019 FY | 1.18 Billion CNY | 38.12% |
| 2018 FY | 854.32 Million CNY | 14.95% |
| 2017 FY | 743.2 Million CNY | 0.0% |